D-0157-2021 Class II Terminated

Recalled by Taro Pharmaceuticals U.S.A., Inc. — Hawthorne, NY

FDA drug recall D-0157-2021 was initiated by Taro Pharmaceuticals U.S.A., Inc. on Nov 17, 2020 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%. The recall status is terminated (terminated Feb 21, 2024). Affected quantity: 11,088 1 oz tubes.

Recall details

Product Type
Drugs
Report Date
Dec 23, 2020
Initiation Date
Nov 17, 2020
Termination Date
Feb 21, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
11,088 1 oz tubes

Product description

Best Choice, Clotrimazole Cream, USP 1%, Antifungal, NET WT 0.5 OZ (14.2g), Distributed by: Valu Merchandisers, CO . 5000 Kansas Ave. Kansas City, KS 66106 Made in Canada. UPC 0-70038-20355-1

Reason for recall

Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.

Distribution pattern

Distributed Nationwide in the USA and Canada

Code information

Lot #: D867331087, Exp Mar, 2021 70,200 63,252

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0157-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0157-2021. Report a data issue: hello@regdatalab.com.